AIDS Treat News. 1999 Jan 8;(No 310):1-3. Unique Identifier : AIDSLINE AIDS/20700011
James JS
Abstract: Although the future of AIDS research is unclear, there are several treatment issues that need to be addressed. One drug that is in development is T-20, an antiviral which may be especially useful to those who have HIV-1 or who have already undergone HIV treatment. Research is also underway to study the body's ability to fight HIV. In addition, measurement techniques are being developed to study the body's immune cell production and lifespan. Other treatment issues are discussed, such as the value of opportunistic infections prophylaxis and alternative or complementary treatments for the immune-suppressed population.
Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .